Quick Answer
Sagimet Biosciences Inc. reported Total Assets of $116.48 million for fiscal year 2025.
Sagimet Biosciences Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $116.48M | -27.3% |
| 2024 | $160.26M | +65.7% |
| 2023 | $96.72M | +192.8% |
| 2022 | $33.03M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $128.40M | -26.5% | -6.6% |
| June 30, 2025 | $137.41M | -27.3% | -6.0% |
| March 31, 2025 | $146.17M | -24.9% | -8.8% |
| December 31, 2024 | $160.26M | +65.7% | -8.3% |
| September 30, 2024 | $174.78M | +69.8% | -7.5% |
| June 30, 2024 | $189.02M | +779.2% | -2.8% |
| March 31, 2024 | $194.53M | — | +101.1% |
| December 31, 2023 | $96.72M | +192.8% | -6.0% |
- Sagimet Biosciences Inc. showed a decrease of -27.3% in Total Assets compared to the prior fiscal year.
- Over the 2022–2025 period, Sagimet Biosciences Inc.’s total assets has grown by 252.6% (from $33.03 million to $116.48 million).
- The most recent figure is from Sagimet Biosciences Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: